Do you ever have time for moments of introspection? Surely the...

Do you ever have time for moments of introspection?

Surely the dawning of a new year provided an opportunity for you to reflect on how you spent the last one? Unfortunately for all of us, these questions are rhetorical as the answer appears self-evident.

I would suggest that most here are invested on a risk adjusted basis on promising clinical signals, and while there may be some outliers I don't think this differs substantively from any company with potential to break new ground, i.e. I'm asserting that a portion of any shareholder base in company with promise, has a similar propensity to overextend or "bet the farm" (something you drone on and on about). How do you reconcile the hypocrisy of your efforts here here given you hold other clinical stage biotechnology companies, some of which who are only in Phase II clinical trials?

Your contributions here, are in a word - trite.